Page last updated: 2024-12-05

nitrosobenzylmethylamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

nitrosobenzylmethylamine: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID13643
CHEMBL ID106823
SCHEMBL ID1165535
MeSH IDM0063452

Synonyms (39)

Synonym
h81cgi9k6z ,
methyl-benzyl-nitrosoamin
benzenemethanamine, n-methyl-n-nitroso-
4-16-00-00871 (beilstein handbook reference)
unii-h81cgi9k6z
nitrosobenzylmethylamine
n-methyl-n-nitrosobenzylamine
n-methyl-n-nitroso-benzenemethanamine
benzylamine, n-methyl-n-nitroso-
benzyl(methyl)nitrosamine
n-nitrosobenzylmethylamine
n-nitroso-n-methylbenzylamine
n-nitroso-n-methyl-n-benzylamine
n-nitrosomethylbenzylamine
brn 1841634
n-methyl-n-benzylnitrosamine
methylbenzylnitrosamine
methyl-benzyl-nitrosoamin [german]
ccris 1120
n-methyl n-benzyl nitrosamine
inchi=1/c8h10n2o/c1-10(9-11)7-8-5-3-2-4-6-8/h2-6h,7h2,1h
937-40-6
n-benzyl-n-methylnitrous amide
CHEMBL106823
FT-0693715
AKOS006283546
SCHEMBL1165535
benzylmethylnitrosamine
1-benzyl-1-methyl-2-oxohydrazine #
benzenemethaneamine, n-methyl-n-nitroso
NGXUJKBJBFLCAR-UHFFFAOYSA-N
benzyl methyl nitrosamine
DTXSID3041081
benzylmethyl nitrosamine
n-methyl-n-nitrosobenzenemethanamine
n-methyl-n-benzylnitrosamine-
benzyl(methyl)nitrosoamine
EN300-392837
Z1198147495

Research Excerpts

Overview

N-Nitrosobenzylmethylamine (NBzMA) is a potent and selective esophageal carcinogen in the rat. NBzMA may be a causative agent for human esphageal cancer.

ExcerptReferenceRelevance
"N-Nitrosobenzylmethylamine (NBzMA) is a potent and selective esophageal carcinogen in the rat and may be a causative agent for human esophageal cancer. "( N-Nitrosobenzylmethylamine hydroxylation and coumarin 7-hydroxylation: catalysis by rat esophageal microsomes and cytochrome P450 2A3 and 2A6 enzymes.
Ding, X; Felicia, ND; Murphy, SE; von Weymarn, LB, 1999
)
1.75

Toxicity

ExcerptReferenceRelevance
" The toxic action of these agents, therefore, mimics the time dependency of their hepatoxicity in vivo."( Toxicity of N-nitrosodimethylamine, N-nitrosomethylbenzylamine, and 1,2-dimethylhydrazine in isolated rat hepatocytes.
Archer, MC; Catz-Biro, L; Chin, W; Hayes, MA; Pollanen, MS, 1990
)
0.28

Pharmacokinetics

ExcerptReferenceRelevance
") was distributed throughout extracellular water and cleared from the whole blood by metabolism with a half-life of 66 min."( In vivo metabolism and whole-blood clearance of n-nitrosomethylbenzylamine in the rat.
Kraft, PL; Skipper, PL; Tannenbaum, SR, 1980
)
0.26

Dosage Studied

ExcerptRelevanceReference
" The dose-response data were subjected to a multiple linear regression equation calculated in a stepwise manner, which found that the differences in mutagenicities could be explained primarily by differences in the three-bond path molecular connectivity index, with smaller contributions from sigma and pi."( Quantitative structure-activity relationship of the mutagenicity of substituted N-nitroso-N-benzylmethylamines: possible implications for carcinogenicity.
Andrews, AW; Guo, SM; Singer, GM, 1986
)
0.27
" MBN dosing was followed by a 12-wk period for tumor promotion."( Effect of selenium and molybdenum on methylbenzylnitrosamine-induced esophageal lesions and tissue trace metals in the rat.
Bogden, JD; Bruening, KS; Chung, HR; Holding, K; Kemp, FW; Naveh, Y, 1986
)
0.27
" Preliminary experiments showed that S-(d3-methyl)cysteine in haemoglobin is formed under the same dosing conditions that result in 7-(d3-methyl)guanine excretion in the urine."( Methylation of protein and nucleic acids in vivo: use of trideuteromethylating agents or precursors.
Bailey, E; Farmer, PB; Shuker, DE, 1984
)
0.27
" One zinc-deficient group was zinc repleted after the dosing period; the other group, zinc-deficient plus 4% ethanol, received 13-cis-retinoic acid (13-cis-RA) after the dosing period."( Zinc deficiency, alcohol, and retinoid: association with esophageal cancer in rats.
Gabrial, GN; Newberne, PM; Schrager, TF, 1982
)
0.26
" beginning 2 weeks prior to NMBA treatment) or following completion of NMBA dosing only."( Effects of dietary phenethyl isothiocyanate, ellagic acid, sulindac and calcium on the induction and progression of N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats.
Barch, DH; Siglin, JC; Stoner, GD, 1995
)
0.29
" While many studies have focused on the pathogenesis of NMBA-induced esophageal tumors, the tumorigenicity of NMBA itself has not been thoroughly investigated in any single, systematic dose-response study."( Evaluation of dose and treatment duration on the esophageal tumorigenicity of N-nitrosomethylbenzylamine in rats.
Khare, L; Siglin, JC; Stoner, GD, 1995
)
0.29
" At 72 h following conclusion of dosing no O6-meGua was detected in the esophagi of rats treated with either regimen."( O6-methylguanine levels and histopathological changes in the rat esophagus and liver following single and repeated administration of N-nitrosomethylbenzylamine.
Conran, PB; Geil, RG; Morse, MA; Schut, HA; Siglin, JC; Stoner, GD, 1996
)
0.29
" Rats that were not dosed with NMBA had no tumors."( Effects of theaflavins on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis.
Balentine, DA; Boone, CW; Harbowy, ME; Kelloff, GJ; Kresty, LA; Morse, MA; Steele, VE; Stoner, GD, 1997
)
0.3
" Animals were placed on control diet and dosed with NMBA three times per week for 5 weeks."( Inhibition of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus by dietary freeze-dried strawberries.
Carlton, PS; Kresty, LA; Lu, J; Morgan, C; Morse, MA; Siglin, JC; Stoner, GD, 2001
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (37)

Assay IDTitleYearJournalArticle
AID202953Activity expressed as no. of revertants per plate in strain TA1535 with and without hamster S9 cells (3 mg/plate) at the dose of 250 ug1983Journal of medicinal chemistry, Mar, Volume: 26, Issue:3
Mutagenicity and chemistry of N-nitroso-N-(p-substituted-benzyl)methylamines.
AID87252compound was tested for mutagenicity against Salmonella tester strain TA 1535 with hamster S9 mix (3 mg/plate) in cells at dose of 25 ug1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Quantitative structure-activity relationship of the mutagenicity of substituted N-nitroso-N-benzylmethylamines: possible implications for carcinogenicity.
AID87121compound was tested for mutagenicity against Salmonella tester strain TA 1535 with out hamster S9 mix (3 mg/plate) in cells.1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Quantitative structure-activity relationship of the mutagenicity of substituted N-nitroso-N-benzylmethylamines: possible implications for carcinogenicity.
AID87120compound was tested for mutagenicity against Salmonella tester strain TA 1535 with hamster S9 mix (3 mg/plate) in cells. Activity expressed as no. of cells1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Quantitative structure-activity relationship of the mutagenicity of substituted N-nitroso-N-benzylmethylamines: possible implications for carcinogenicity.
AID202950Activity expressed as no. of revertants per plate in strain TA1535 with and without hamster S9 cells (3 mg/plate) at the dose of 1 ug1983Journal of medicinal chemistry, Mar, Volume: 26, Issue:3
Mutagenicity and chemistry of N-nitroso-N-(p-substituted-benzyl)methylamines.
AID87255compound was tested for mutagenicity against Salmonella tester strain TA 1535 with hamster S9 mix (3 mg/plate) in cells at dose of 5 ug1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Quantitative structure-activity relationship of the mutagenicity of substituted N-nitroso-N-benzylmethylamines: possible implications for carcinogenicity.
AID202957Activity expressed as no. of revertants per plate in strain TA1535 with and without hamster S9 cells (3 mg/plate) at the dose of 5 ug1983Journal of medicinal chemistry, Mar, Volume: 26, Issue:3
Mutagenicity and chemistry of N-nitroso-N-(p-substituted-benzyl)methylamines.
AID202954Activity expressed as no. of revertants per plate in strain TA1535 with and without hamster S9 cells (3 mg/plate) at the dose of 25 ug1983Journal of medicinal chemistry, Mar, Volume: 26, Issue:3
Mutagenicity and chemistry of N-nitroso-N-(p-substituted-benzyl)methylamines.
AID202948Activity expressed as no. of revertants per plate in strain TA1535 with and without hamster S9 cells (3 mg/plate) at the dose of 100 ug1983Journal of medicinal chemistry, Mar, Volume: 26, Issue:3
Mutagenicity and chemistry of N-nitroso-N-(p-substituted-benzyl)methylamines.
AID87260compound was tested for mutagenicity against Salmonella tester strain TA 1535 with out hamster S9 mix (3 mg/plate) in cells at dose of 2.5 ug1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Quantitative structure-activity relationship of the mutagenicity of substituted N-nitroso-N-benzylmethylamines: possible implications for carcinogenicity.
AID202956Activity expressed as no. of revertants per plate in Salmonella Typhimurium TA1535 with and without hamster S9 cells (3 mg/plate) at the dose of 50 ug1983Journal of medicinal chemistry, Mar, Volume: 26, Issue:3
Mutagenicity and chemistry of N-nitroso-N-(p-substituted-benzyl)methylamines.
AID87265compound was tested for mutagenicity against Salmonella tester strain TA 1535 with out hamster S9 mix (3 mg/plate) in cells at dose of 5 ug1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Quantitative structure-activity relationship of the mutagenicity of substituted N-nitroso-N-benzylmethylamines: possible implications for carcinogenicity.
AID87257compound was tested for mutagenicity against Salmonella tester strain TA 1535 with out hamster S9 mix (3 mg/plate) in cells at dose of 100 ug1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Quantitative structure-activity relationship of the mutagenicity of substituted N-nitroso-N-benzylmethylamines: possible implications for carcinogenicity.
AID87119compound was tested for mutagenicity against Salmonella tester strain TA 1535 with hamster S9 mix (3 mg/plate) in cells.1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Quantitative structure-activity relationship of the mutagenicity of substituted N-nitroso-N-benzylmethylamines: possible implications for carcinogenicity.
AID202958Activity expressed as no. of revertants per plate in strain TA1535 with hamster S9 cells (3 mg/plate)1983Journal of medicinal chemistry, Mar, Volume: 26, Issue:3
Mutagenicity and chemistry of N-nitroso-N-(p-substituted-benzyl)methylamines.
AID87124compound was tested for mutagenicity against Salmonella tester strain TA 1535 with hamster S9 mix (3 mg/plate) in cells at dose of 100 ug1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Quantitative structure-activity relationship of the mutagenicity of substituted N-nitroso-N-benzylmethylamines: possible implications for carcinogenicity.
AID202951Activity expressed as no. of revertants per plate in strain TA1535 with and without hamster S9 cells (3 mg/plate) at the dose of 2.5 ug1983Journal of medicinal chemistry, Mar, Volume: 26, Issue:3
Mutagenicity and chemistry of N-nitroso-N-(p-substituted-benzyl)methylamines.
AID87262compound was tested for mutagenicity against Salmonella tester strain TA 1535 with out hamster S9 mix (3 mg/plate) in cells at dose of 25 ug1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Quantitative structure-activity relationship of the mutagenicity of substituted N-nitroso-N-benzylmethylamines: possible implications for carcinogenicity.
AID87256compound was tested for mutagenicity against Salmonella tester strain TA 1535 with out hamster S9 mix (3 mg/plate) in cells at dose of 1000 ug1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Quantitative structure-activity relationship of the mutagenicity of substituted N-nitroso-N-benzylmethylamines: possible implications for carcinogenicity.
AID87248compound was tested for mutagenicity against Salmonella tester strain TA 1535 with hamster S9 mix (3 mg/plate) in cells at dose of 10 ug1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Quantitative structure-activity relationship of the mutagenicity of substituted N-nitroso-N-benzylmethylamines: possible implications for carcinogenicity.
AID87254compound was tested for mutagenicity against Salmonella tester strain TA 1535 with hamster S9 mix (3 mg/plate) in cells at dose of 50 ug1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Quantitative structure-activity relationship of the mutagenicity of substituted N-nitroso-N-benzylmethylamines: possible implications for carcinogenicity.
AID202955Activity expressed as no. of revertants per plate in strain TA1535 with and without hamster S9 cells (3 mg/plate) at the dose of 500 ug1983Journal of medicinal chemistry, Mar, Volume: 26, Issue:3
Mutagenicity and chemistry of N-nitroso-N-(p-substituted-benzyl)methylamines.
AID87253compound was tested for mutagenicity against Salmonella tester strain TA 1535 with hamster S9 mix (3 mg/plate) in cells at dose of 500 ug1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Quantitative structure-activity relationship of the mutagenicity of substituted N-nitroso-N-benzylmethylamines: possible implications for carcinogenicity.
AID226732The compound was modelled in silico for carcinogenic potency; + = Carcinogen1982Journal of medicinal chemistry, Jul, Volume: 25, Issue:7
Computer-assisted studies of structure-activity relationships of N-nitroso compounds using pattern recognition.
AID87123compound was tested for mutagenicity against Salmonella tester strain TA 1535 with hamster S9 mix (3 mg/plate) in cells at dose of 1000 ug1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Quantitative structure-activity relationship of the mutagenicity of substituted N-nitroso-N-benzylmethylamines: possible implications for carcinogenicity.
AID87251compound was tested for mutagenicity against Salmonella tester strain TA 1535 with hamster S9 mix (3 mg/plate) in cells at dose of 250 ug1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Quantitative structure-activity relationship of the mutagenicity of substituted N-nitroso-N-benzylmethylamines: possible implications for carcinogenicity.
AID28498Concentration in nmol/plate to induce 50 revertants/plate.1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Quantitative structure-activity relationship of the mutagenicity of substituted N-nitroso-N-benzylmethylamines: possible implications for carcinogenicity.
AID87122Mutagenicity against Salmonella tester strain TA 1535 without hamster S9 mix (3 mg/plate) in cells.1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Quantitative structure-activity relationship of the mutagenicity of substituted N-nitroso-N-benzylmethylamines: possible implications for carcinogenicity.
AID202947Activity expressed as no. of revertants per plate in strain TA1535 with and without hamster S9 cells (3 mg/plate) at the dose of 1000 ug1983Journal of medicinal chemistry, Mar, Volume: 26, Issue:3
Mutagenicity and chemistry of N-nitroso-N-(p-substituted-benzyl)methylamines.
AID87259compound was tested for mutagenicity against Salmonella tester strain TA 1535 with out hamster S9 mix (3 mg/plate) in cells at dose of 1 ug1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Quantitative structure-activity relationship of the mutagenicity of substituted N-nitroso-N-benzylmethylamines: possible implications for carcinogenicity.
AID87250compound was tested for mutagenicity against Salmonella tester strain TA 1535 with hamster S9 mix (3 mg/plate) in cells at dose of 2.5 ug1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Quantitative structure-activity relationship of the mutagenicity of substituted N-nitroso-N-benzylmethylamines: possible implications for carcinogenicity.
AID87118compound was tested for mutagenicity against Salmonella tester strain TA 1535 with out hamster S9 mix (3 mg/plate) in cells at dose of 50 ug1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Quantitative structure-activity relationship of the mutagenicity of substituted N-nitroso-N-benzylmethylamines: possible implications for carcinogenicity.
AID87258compound was tested for mutagenicity against Salmonella tester strain TA 1535 with out hamster S9 mix (3 mg/plate) in cells at dose of 10 ug1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Quantitative structure-activity relationship of the mutagenicity of substituted N-nitroso-N-benzylmethylamines: possible implications for carcinogenicity.
AID87261compound was tested for mutagenicity against Salmonella tester strain TA 1535 with out hamster S9 mix (3 mg/plate) in cells at dose of 250 ug1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Quantitative structure-activity relationship of the mutagenicity of substituted N-nitroso-N-benzylmethylamines: possible implications for carcinogenicity.
AID87249compound was tested for mutagenicity against Salmonella tester strain TA 1535 with hamster S9 mix (3 mg/plate) in cells at dose of 1 ug1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Quantitative structure-activity relationship of the mutagenicity of substituted N-nitroso-N-benzylmethylamines: possible implications for carcinogenicity.
AID87263compound was tested for mutagenicity against Salmonella tester strain TA 1535 with out hamster S9 mix (3 mg/plate) in cells at dose of 500 ug1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Quantitative structure-activity relationship of the mutagenicity of substituted N-nitroso-N-benzylmethylamines: possible implications for carcinogenicity.
AID202949Activity expressed as no. of revertants per plate in strain TA1535 with and without hamster S9 cells (3 mg/plate) at the dose of 10 ug1983Journal of medicinal chemistry, Mar, Volume: 26, Issue:3
Mutagenicity and chemistry of N-nitroso-N-(p-substituted-benzyl)methylamines.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (270)

TimeframeStudies, This Drug (%)All Drugs %
pre-199090 (33.33)18.7374
1990's94 (34.81)18.2507
2000's57 (21.11)29.6817
2010's24 (8.89)24.3611
2020's5 (1.85)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 8.71

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index8.71 (24.57)
Research Supply Index5.63 (2.92)
Research Growth Index4.34 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (8.71)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews9 (3.23%)6.00%
Case Studies1 (0.36%)4.05%
Observational0 (0.00%)0.25%
Other269 (96.42%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]